We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Antigen-Based Assay Detects Tick-Borne Diseases Before Symptoms Appear

By LabMedica International staff writers
Posted on 04 Feb 2025

Tick-borne spotted fever rickettsioses (SFRs) continue to pose a significant threat to otherwise healthy individuals, causing severe illness and death due to the lack of a reliable and timely diagnostic laboratory test. More...

The absence of specific, convenient, acute-phase diagnostic tests for SFRs contributes to their difficulty in diagnosis and underreporting. Currently, the gold standard for diagnosing tick-borne rickettsioses involves detecting antibodies against rickettsiae in the serum through indirect immunofluorescence assay (IFA). However, this antibody response typically appears 7 to 10 days after illness onset, when fatalities often occur. While molecular detection of bacterial DNA and immunohistochemical analysis of rickettsial antigens in skin biopsies may provide early diagnosis, the occurrence of skin rashes and their timing are unreliable. Furthermore, many hospital laboratories do not perform rapid molecular diagnostic testing for SFRs. Researchers have now identified a biomarker for SFRs, leading to the development of a prototype laboratory test aimed at detecting this biomarker for more accurate diagnosis.

Researchers at University of Houston (Houston, TX, USA) have identified a rickettsial protein, RC0497, in R. conorii-infected endothelial cell supernatant. RC0497, a putative N-acetylmuramoyl-L-alanine amidase, is highly conserved across various SFG species. The researchers showed that RC0497 is present in the blood of both infected mouse models of Mediterranean spotted fever (MSF) and MSF patients. In this study, the researchers tested the hypothesis that detecting RC0497 through a rapid lateral flow assay (LFA) could provide a timely diagnostic tool, potentially improving treatment outcomes for severe SFRs. The team used two experimental models of SFRs—R. conorii-infected C3H/HeN mice and R. rickettsii-infected guinea pigs—which replicate the pathophysiological changes seen in patients with Rocky Mountain spotted fever (RMSF). They measured RC0497 concentrations at various disease stages by mass spectrometry (MS) using blood samples from infected animals.

Using specific antibodies against RC0497 and europium chelate nanoparticle reporters, the researchers developed a europium nanoparticle LFA (EuNP LFA) to detect this biomarker for SFRs. The assay demonstrated high analytical sensitivity and specificity in serum samples from experimentally infected animals at the early stages of infection, when antibiotics could still control rickettsiae. The results suggest that detecting RC0497 in a timely manner using the europium LFA could guide treatment, significantly improving infection outcomes. This represents the first rapid antigen-detection test prototype based on a lateral flow assay platform for diagnosing life-threatening SFRs in a timely manner.

The research confirmed that a rickettsial antigen, detectable by a simple test, is present in the circulation of infected animals. Unlike serological tests used to detect past exposure to potentially nonpathogenic rickettsial species, the RC0497 LFA can distinguish active infections. This will enhance clinical diagnosis and epidemiological surveillance. Although further validation with patient specimens is needed, the team has established proof-of-concept for an LFA that could potentially be developed into a point-of-care diagnostic tool for use in real-world settings.


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.